NCT01088503 Treatment With Adenosine Diphosphate (ADP) Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome Status COMPLETED Phase N/A
NCT01077154 Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE) Status TERMINATED Phase PHASE3
NCT01075048 ARQ 197 in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01066364 Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis Status COMPLETED Phase PHASE2
NCT01062269 A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study Status COMPLETED Phase PHASE4
NCT01055067 ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors Status TERMINATED Phase PHASE2
NCT01049893 Dose Finding, Safety and Tolerability Study for AC220 to Treat Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01033240 CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer Status COMPLETED Phase PHASE2
NCT00993824 Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2/PHASE3
NCT00991796 CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00989261 Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE2
NCT00986440 Study of CS-7017 in Colorectal Cancer Patients Who Have Achieved Disease Control Following First-Line Chemotherapy Status TERMINATED Phase PHASE2
NCT00986154 Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). Status COMPLETED Phase PHASE3
NCT00969033 CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin Status TERMINATED Phase PHASE2
NCT00967616 Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy Status COMPLETED Phase PHASE2
NCT00951899 The Effect of Welchol on Glucose Metabolism in Type 2 Diabetics Status COMPLETED Phase PHASE4